Novavax, COVID
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer.
For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair’
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. t
On the hunt for Novavax: Why people are seeking out the 'traditional' COVID vaccine
Some people are making it their mission to get Novavax, rather than Pfizer or Moderna, for their COVID booster.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season.
Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
The Public Health Agency of Canada says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year
TORONTO - The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing low demand.
Is the Novavax COVID-19 Vaccine Better?
While the new mRNA vaccines from Moderna and Pfizer-BioNTech have dominated the COVID-19 vaccine story, there is another type ...
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
Novavax (NVAX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...
bovnews1d
Novavax Inc (NVAX) Stock: Surpassing Expectations in the Market?
On Thursday, Novavax Inc (NVAX) stock saw a decline, ending the day at $14.42 which represents a decrease of $-0.26 or -1.77% from the prior close of $14.68. The stock opened at $14.07 and touched a ...
Novavax Inc. stock underperforms Friday when compared to competitors
Shares of Novavax Inc. NVAX shed 5.62% to $13.61 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.22% to ...
Seeking Alpha2d
Novavax cools after clarifying analyst report on COVID vaccine market
Novavax (NASDAQ:NVAX) shares fell ~3% in the premarket on Thursday after the company issued a clarification on an analyst report on the U.S. COVID-19 vaccine market that led to a sharp rally in ...
Jefferies Sticks to Their Buy Rating for Novavax (NVAX)
In a report released today, Roger Song from Jefferies maintained a Buy rating on Novavax (NVAX – Research Report), with a price target of ...
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...